🇮🇹 SATRALIZUMAB in Italy

SATRALIZUMAB (SATRALIZUMAB) regulatory status in Italy.

Marketing authorisation

AIFA

  • Local brand name: Enspryng
  • Status: approved

SATRALIZUMAB in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is SATRALIZUMAB approved in Italy?

Yes. AIFA has authorised it.

Who is the marketing authorisation holder for SATRALIZUMAB in Italy?

Marketing authorisation holder not available in our data.